Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, N14 W5, Kita-ku, Sapporo, 060-8648, Japan.
Diagnostic Center for Sonography, Hokkaido University Hospital, Sapporo, Japan.
Int J Hematol. 2021 Jul;114(1):94-101. doi: 10.1007/s12185-021-03137-3. Epub 2021 Mar 24.
Hepatic sinusoidal obstruction syndrome (SOS)/veno-occlusive disease is a life-threatening complication after hematopoietic stem cell transplantation (HSCT). We previously reported the efficacy of the Hokkaido Ultrasonography (US)-based scoring system (HokUS-10) for US findings. To establish easier-to-use criteria, we retrospectively evaluated US findings from 441 patients, including 30 patients with SOS using the HokUS-10 scoring system. Using logistic regression analysis, we established the novel diagnostic criteria HokUS-6. In the presence of ascites, US diagnosis was made in the presence of two of the following 6 parameters: moderate amount of ascites, the appearance of a paraumbilical vein blood flow signal, gallbladder wall thickening, portal vein dilatation, portal vein velocity decrease, and hepatic artery resistive index increase. The AUC, sensitivity, and specificity of HokUS-6 were 0.974 (95% confidence interval 0.962-0.990), 95.2%, and 96.9%, respectively. The scores were significantly higher in patients with severe SOS than in those with non-severe SOS (p = 0.013). Furthermore, the scores before HSCT were significantly higher in patients who developed SOS than in controls (p = 0.001). The HokUS-6 is an easy and useful way to diagnose and identify the risk of SOS.
肝窦阻塞综合征(SOS)/静脉阻塞性疾病是造血干细胞移植(HSCT)后一种危及生命的并发症。我们之前报道了北海道超声(US)评分系统(HokUS-10)对 US 表现的疗效。为了建立更易于使用的标准,我们回顾性评估了 441 名患者的 US 表现,包括 30 名 SOS 患者,使用 HokUS-10 评分系统。使用逻辑回归分析,我们建立了新的诊断标准 HokUS-6。在腹水存在的情况下,US 诊断为以下 6 个参数中的两个:中等量腹水、脐旁静脉血流信号出现、胆囊壁增厚、门静脉扩张、门静脉速度降低和肝动脉阻力指数增加。HokUS-6 的 AUC、敏感性和特异性分别为 0.974(95%置信区间 0.962-0.990)、95.2%和 96.9%。严重 SOS 患者的评分明显高于非严重 SOS 患者(p=0.013)。此外,发生 SOS 的患者 HSCT 前的评分明显高于对照组(p=0.001)。HokUS-6 是一种简单而有用的方法,可用于诊断和识别 SOS 的风险。